Benzinga's Small Cap Movers for Tuesday January 15, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves:
Shares of Zippy Bags (OTC: ZPPB), the Las Vegas, NV specialty hybrid sporting goods bag manufacturing company, rose 218% Tuesday on 3,079 times average volume.
Zippy Bags announced Tuesday that it has secured a new sales agreement for 12,000 Zippy Bike Bags with World Wide Wholesale Inc., which will further assist in the global expansion of the product lines.
Zippy Bags closed at $0.29 on Tuesday.
Shares of BioLineRx (NASDAQ: BLRX), the Israel-based biopharmaceutical company, rose 14% Tuesday on 12 times average volume.
A Seeking Alpha article about BioLineRx's Schizophrenia Drug appears to be the catalyst for Tuesday's move.
BioLineRx closed at $3.35 on Tuesday.
Shares of Neptune Technologies & Bioresources (NASDAQ: NEPT), the Laval, QB biotechnology company, rose 10% Tuesday on twice average volume.
Neptune Technologies reported Monday its consolidated financial results for the three and nine-month periods ended November 30, 2012 and announces that it will receive a first insurance payment. Revenues increased by 37% to $7,027,000 for the three-month period ended November 30, 2012, up from $5,120,000 achieved during the corresponding period ended November 30, 2011.
In addition, Neptune has received confirmation from its insurer that it will receive a first interim payment of $6 million further to the explosion that destroyed Neptune's production plant.
Neptune Technologies closed at $2.65 on Tuesday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.